Keywords
Treatment
Mycoplasma pneumonia in children
Submitted : 2024-04-10
Accepted : 2024-04-25
Published : 2024-05-10
Abstract
Objective: To discuss and analyze the effect of azithromycin in the treatment of mycoplasma pneumonia in children. Methods: A total of 120 children with mycoplasma pneumonia who were admitted to the Department of Pediatrics of our hospital from January 2022 to December 2022 were selected as the research subjects. They were divided into an azithromycin group and a reference group according to the random number drawing method, with 60 cases in each group. The azithromycin group was treated with azithromycin, and the reference group was treated with conventional treatment. The efficacy of treatment, laboratory indicators, platelet count and D-dimer, and adverse reactions of both groups were compared. Results: The efficacy of the azithromycin group was significantly higher than that of the reference group (P < 0.05). Before treatment, there were no significant differences in the laboratory indicators like ferritin, procalcitonin (PCT), and erythrocyte sedimentation rate (ESR) between the two groups (P > 0.05); after treatment, the laboratory indicators of the azithromycin group were significantly better than those of the reference group (P < 0.05). Before treatment, there was no statistically significant difference in platelet count and D-dimer between the groups (P > 0.05); after medication, the platelet count, and D-dimer in the azithromycin group were significantly better than those in the reference group (P < 0.05). The total incidence of adverse reactions in the azithromycin group was significantly lower than that in the reference group (P < 0.05). Conclusion: Azithromycin is more effective in treating mycoplasma pneumonia in children, and has certain clinical value.
References
Li S, Zhang Y, Liu X, 2023, The Curative Effect of Modified Maxing Shigan Decoction Combined with Azithromycin Sequential Therapy in the Treatment of Children with Mycoplasma Pneumonia and its Effect on Serum Inflammatory Factors and Oxidative Stress. Journal of Clinical and Experimental Medicine, 22(08): 870–875.
Liang W, Wu X, Yan H, et al., 2023, The Curative Effect of Bailing Capsules Combined with Azithromycin in the Treatment of Children with Mycoplasma Pneumonia and its Effect on Serum sPD-1 and CYTL1 Levels. Journal of Difficult and Difficult Diseases, 22(02): 124–131.
Wang L, Zhou R, 2020, Effect of Methylprednisolone Combined with Azithromycin on Serum ECP Level, Blood Gas Analysis Indicators and Alveolar Ventilation in Children with Mycoplasma Pneumonia. Hainan Medicine, 31(22): 2931–2934.
Tong X, Tang X, Chen D, 2022, Effects of Acetylcysteine Combined with Azithromycin Sequential Therapy and Ambroxol on Ventilation Status, Inflammatory Factors, Th17 and Treg Levels in Children with Mycoplasma Pneumonia. Clinical Medicine Research and Practice, 7(35): 102–105.
Li J, Zhang K, Zhou J, et al., 2022, Evaluation of the Effectiveness, Safety, and Economics of 6 Oral Chinese Patent Medicines Combined with Azithromycin in the Treatment of Children with Mycoplasma Pneumonia Based on Network Meta-Analysis. China Pharmaceutical Economics, 17(08): 22–31.
Yu L, Zheng J, 2022, The Curative Effect of Vitamin C Supplemented with Azithromycin in the Treatment of Mycoplasma Pneumonia in Children and the Effect on the Levels of C-Reactive Protein Tumor Necrosis Factor-? and Procalcitonin. China Maternal and Child Health, 37(15): 2815–2818.
Zhao Q, Yuan H, Li S, 2022, Modified Maxing Shigan Decoction Combined with Azithromycin In the Treatment of Mycoplasma Pneumonia in Children and its Effect on the Body’s Cellular Immune Response, Serum FBG and G-CSF Levels. Modern Journal of Integrated Traditional Chinese and Western Medicine, 31(10): 1399–1402.
Zhang J, Xia R, Zhu X, 2022, Effects of Montelukast Sodium Treatment on Mycoplasma Pneumonia in Children on the Expression of Serum Interleukin, sB7-H3, IFN-?, and GM-CSF. Contemporary Medicine, 28(10): 64–66.
Liu C, Tian Y, Ma J, 2022, Clinical Effect of Azithromycin, Terbutaline Combined with Budesonide Nebulized Inhalation in the Treatment of Children with Mycoplasma Pneumonia and its Influence on Blood Gas Analysis Indicators and Serum Inflammatory Factors. Clinical Medicine Research and Practice, 7(06): 37–39.
Wu J, Huang X, Wen W, 2021, The Clinical Effect of Nebulized Terbutaline Inhalation Combined with Azithromycin in the Treatment of Children with Mycoplasma Pneumonia and its Influence on the Level of Inflammatory Factors. Chinese Community Physician, 37(22): 19–20.
Zhang H, Yan Y, Qiu J, et al., 2021, Effect of Nebulized Inhalation of Acetylcysteine Solution Combined with Sequential Therapy of Azithromycin on Blood Gas Analysis and Oxidative Stress Indicators of Children with Mycoplasma Pneumonia. Clinical Medicine Research and Practice, 6(22): 98–100.
Li L, Wang Y, Xu Z, 2021, Efficacy and Safety of Qingfei Tongfu Xietan Decoction Combined with Azithromycin in the Treatment of Mycoplasma Pneumonia Complicated with Atelectasis in Children with Phlegm-Heat Blocking the Lungs. Modern Journal of Integrated Traditional Chinese and Western Medicine, 30(14): 1516–1520.
Wang W, Zhang J, Zhao R, et al., 2021, Efficacy of Clearing the Lung, Relieving Convulsion and Promoting Blood Circulation Combined with Azithromycin in the Treatment of Children with Mycoplasma Pneumonia Syndrome of Phlegm-Heat Closing the Lung and Its Influence on Platelets and D-dimer. Thrombosis and Hemostasis, 27(02): 242–243 + 246.
Wei J, Gao L, Liu X, 2020, The Curative Effect of Pidotimod Combined with Azithromycin in the Treatment of Children with Mycoplasma Pneumonia and its Influence on the Levels of Serum Interleukin-10 and Granulocyte Colony-Stimulating Factor. Shanxi Medicine Journal, 49(23): 3253–3255.
Yu D, Zhang X, 2020, Observation on the Effect of Xiyanping Combined with Azithromycin Sequential Therapy on Peripheral Blood Th1/Th2 Expression and Lung Function in Children with Mycoplasma Pneumonia. Sichuan Anatomy Journal, 28(04): 27–28.